Morgan Stanley Q3 EPS Beats by $0.73; Analysts Raise Targets to $202, $170
Morgan Stanley reported Q3 EPS of $2.80, beating consensus by $0.73, with revenue of $17.98 billion up 18.5% year-over-year. Keefe Bruyette & Woods raised its price target to $202 and Citigroup lifted its objective to $170, while MarketBeat’s consensus rating remains Moderate Buy from 18 analysts.
1. Morgan Stanley Projects Venezuela Crude Exports to Double
In a detailed research note released this week, Morgan Stanley forecast that Venezuela’s heavy crude exports could rise from approximately 800,000 barrels per day in 2025 to 1.6 million barrels per day by 2027, driven by renewed investment in state‐owned PDVSA facilities and easing of logistical bottlenecks at maritime terminals in the Caribbean. The report highlights that the country produced around 900,000 barrels per day last year, with China accounting for roughly 65% of shipments and the United States receiving close to 140,000 barrels per day. Analysts at the bank argue that an inflow of additional heavy sour grades into the Atlantic basin would exert downward pressure on regional discount levels to benchmark Brent, potentially widening the pricing gap between heavy and light crudes by as much as $6 per barrel. The team also modeled scenarios in which surging Venezuelan volumes reorient trade flows in West Africa and Mexico, forecasting a 15% drop in Urals and Maya crude valuations relative to Brent over the next 24 months.
2. Moderate Buy Consensus and Recent Analyst Activity
According to data compiled by Marketbeat, eighteen brokerages covering Morgan Stanley have issued ratings that converge on a consensus of “Moderate Buy,” with eight analysts endorsing a buy stance, three elevating their view to strong buy, and seven recommending a hold. The average twelve‐month price target across these firms stands at $174.77. In recent weeks, Keefe, Bruyette & Woods raised its target to $202 while maintaining an outperform call, Citigroup lifted its objective to $170 with a neutral rating, and Wolfe Research upgraded to outperform with a $198 price goal. Over the past quarter, Goldmansachs adjusted its projection up to $164, and Weiss Ratings reaffirmed a buy (b‐) posture.
3. Insider Selling and Institutional Positioning
Corporate filings reveal that CEO Edward Pick sold 100,000 shares on October 31 at an average of $164.34, realizing proceeds of $16.43 million and reducing his stake by 14.8% to 574,986 shares valued at approximately $94.5 million. This transaction leaves insiders holding 0.19% of outstanding shares. On the institutional front, Vanguard Group increased its stake by 1.1% to 119.1 million shares, Capital International added 0.6% to reach 27.3 million shares, and Fisher Asset Management upped its position by 1.9% to 24.5 million shares. Norges Bank initiated a 13.6 million‐share position, while Ameriprise Financial boosted its holdings by 6.1% to 14.3 million shares. Collectively, hedge funds and other institutions now account for 84.2% of Morgan Stanley’s equity base.